BioSpace News Archive

Business

Spero Therapeutics Announces Third Quarter 2020 Operating Results and Provides Business Update

Achieved key clinical milestones with positive ADAPT-PO Phase 3 data and SPR720 IND acceptance

November 5, 2020
·
14 min read
Business

ORIC Pharmaceuticals Reports Third Quarter 2020 Financial and Operational Update

Expanded precision oncology pipeline through in-licensing of allostericPRC2 inhibitor program and brain penetrant EGFR and HER2 exon 20 inhibitor program

November 5, 2020
·
11 min read
Business

Fluidigm Announces Third Quarter 2020 Financial Results

Fluidigm Corporation, an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, announced financial results for the third quarter ended September 30, 2020.

November 5, 2020
·
18 min read
Business

Editas Medicine Announces Third Quarter 2020 Results and Update

Editas Medicine, Inc., a leading genome editing company, reported business highlights and financial results for the third quarter of 2020.

November 5, 2020
·
13 min read
Business

Aerpio Pharmaceuticals to Report Third Quarter 2020 Financial Results on November 10

Aerpio Pharmaceuticals, Inc. will release its financial results for the third quarter ended September 30, 2020, before the market open on Tuesday, November 10, 2020, and host a webcast and conference call at 8:30am ET.

November 5, 2020
·
2 min read
BioMidwest

Aerpio Hosting Key Opinion Leader Call on New Therapeutic Agents for COVID-19Call Taking Place on Thursday, November 12th @ 11amET

Aerpio Pharmaceuticals, Inc. announced that it will host a key opinion leader call on new therapeutic agents for the treatment of COVID-19 on Thursday, November 12, 2020 at 11am Eastern Time.

November 5, 2020
·
8 min read
Business

Entasis Therapeutics Reports Third Quarter 2020 Financial Results and Provides a Business Update

Entasis Therapeutics Holdings Inc., a clinical-stage biopharmaceutical company focused on the discovery and development of novel antibacterial products, announced its third quarter 2020 financial results and provided a business update.

November 5, 2020
·
9 min read
Business

Bellicum Reports Third Quarter 2020 Financial Results and Provides Operational Update

Strategic focus on clinical GoCAR-T® programs with plans to initiate Phase 1/2 enrollment of BPX-601 in mCRPC and BPX-603 in HER2+ solid tumors by end of year

November 5, 2020
·
9 min read
Drug Development

Assembly Biosciences Provides Update on the Ongoing Phase 2 Extension Study of Vebicorvir in Patients with Chronic Hepatitis B Virus Infection

HBV field’sfirstcore inhibitor combination study to assess off-treatmentresponse has not achieved a meaningful rate ofsustained virologic response

November 5, 2020
·
10 min read
Business

Misonix Fiscal 2021 First Quarter Revenue Rises 59% to $17.7 Million

Misonix, Inc., a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance clinical outcomes, reported unaudited financial results for the fiscal 2021 first quarter ended September 30, 2020 as summarized below:

November 5, 2020
·
13 min read